Full Text (PDF)
Original Article

Rebound Hyperbilirubinaemia Following Intensive Phototherapy

Basavaraj M. Patil, Associate Professor, Department of Pediatrics, Mahadevappa Rampure Medical College, Kalaburagi, Karnataka 585105, India. , Basavaraj M. Patil1 , Harsha A. Sangolgikar2

Author Information

Licence:




Pediatric Education and Research 6(2):p 120-123, May - August 2018. | DOI: DOI: https://dx.doi.org/10.21088/per.2321.1644.6218.15

How Cite This Article:


Timeline

Received : N/A         Accepted : N/A          Published : N/A

Abstract

This prospective study was conducted in tertiary care hospital attached to Department of pediatrics, Mahadevappa Rampure Medical college Kalburgi.

Aims: To determine the incidence of post phototherapy rebound hyperbilirubenemia in neonates subjected to phototherapy.

Materials and Methods: All babies with hyperbilirubinemia admitted to nicu were included in the study . A total of 200 neonates among which 122 were males and 78 were females. Repeat serum bilirubin was measured 24 hours after stopping phototherapy.

Statistical analysis: Data entry analysis were done using SPSS.

Results: The general incidence of significant rebound hyperbilirubinemia requiring reinitiation of phototherapy was 9.5%. Birth weight and gestation age has significant impact on rebound hyperbilirubinemia.

Conclusion: it is necessary to measure rebound bilirubin levels after 24 hrs of stoppage of phototherapy in high risk neonates like premature babies, birth weight <2kg.

Keywords: Bilirubin; Phototherapy; Significant Rebound.

 


References

No records found.


About this article


Cite this article


Licence:




Received Accepted Published
N/A N/A N/A

DOI: DOI: https://dx.doi.org/10.21088/per.2321.1644.6218.15

Keywords


Article Level Metrics

Last Updated

Friday 19 June 2026, 20:40:41 (IST)


617

Accesses

5
110
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received N/A
Accepted N/A
Published N/A

licence



Access this article



Share